Menu

Alzamend Neuro, Inc. ALZN

Full chart Compare
Set alert

Price alert · ALZN

All alert types
1.55 USD +0.02 (+1.31%)

At closeNov 5, 2026, 6:18 PM EST

1.51 -0.04 -2.58%

After hours · Nov 5, 6:18 PM ET

1.51 Day range 1.62
0.84 52-week range 2.58
YTD
-14.84%
1 year
-39.22%

Financial health

Altman Z-Score

-12.63 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -0.4×
FY 2017: -248×FY 2018: -658×FY 2019: -163×FY 2020: -218×FY 2021: -194×FY 2022: -7.4×FY 2023: -3.5×FY 2024: -0.5×FY 2025: -0.5×FY 2026: -0.4×
FY 2017 5y median -0.5× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 5.2×
FY 2017: -654×FY 2018: 259×FY 2019: 2473×FY 2020: 1153×FY 2021: 480×FY 2022: 6.7×FY 2023: 17.0×FY 2024: -1.9×FY 2025: 0.6×FY 2026: 5.2×
FY 2017 5y median 5.2× FY 2026
P/FCF -0.5×
FY 2017: -270×FY 2018: -293×FY 2019: -750×FY 2020: -404×FY 2021: -356×FY 2022: -13.3×FY 2023: -5.8×FY 2024: -0.6×FY 2025: -0.3×FY 2026: -0.5×
FY 2017 5y median -0.6× FY 2026
EV/EBITDA -0.4×
FY 2017: 965520×FY 2018: 80872×FY 2019: -156×FY 2020: -215×FY 2021: -195×FY 2022: -6.1×FY 2023: -3.1×FY 2024: -0.5×FY 2025: 0.4×FY 2026: -0.4×
FY 2017 5y median -0.5× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -212.1%
FY 2017: -0.4%FY 2018: -0.3%FY 2019: -0.1%FY 2020: -0.2%FY 2021: -0.3%FY 2022: -7.5%FY 2023: -17.3%FY 2024: -175.4%FY 2025: -290.5%FY 2026: -212.1%
FY 2017 5y median -175.4% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -1196.4%
FY 2017: 268.4%FY 2018: -40.2%FY 2019: -1534.3%FY 2020: -536.7%FY 2021: -250.7%FY 2022: -92.6%FY 2023: -488.5%FY 2024: 383.5%FY 2025: -113.8%FY 2026: -1196.4%
FY 2017 5y median -113.8% FY 2026
ROIC -1195.7%
FY 2017: -24462.7%FY 2018: -38.7%FY 2019: -1580.1%FY 2020: -538.4%FY 2021: -210.9%FY 2022: -92.3%FY 2023: -488.3%FY 2024: 433.3%FY 2025: -113.3%FY 2026: -1195.7%
FY 2017 5y median -113.3% FY 2026
ROA -421.9%
FY 2017: -1186.8%FY 2018: -38.6%FY 2019: -324.0%FY 2020: -243.1%FY 2021: -173.3%FY 2022: -85.2%FY 2023: -251.5%FY 2024: -1575.0%FY 2025: -98.1%FY 2026: -421.9%
FY 2017 5y median -251.5% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income -95.0%
FY 2017: -2128.7%FY 2018: 42.0%FY 2019: -457.8%FY 2020: 11.7%FY 2021: -11.9%FY 2022: -148.8%FY 2023: -20.7%FY 2024: 33.2%FY 2025: 54.7%FY 2026: -95.0%
FY 2017 FY 2026
EPS (diluted) 76.8%
FY 2017: 0.0%FY 2018: 62.3%FY 2019: -302.6%FY 2020: 25.1%FY 2021: -12.2%FY 2022: -99.7%FY 2023: -10.0%FY 2024: 35.8%FY 2025: 91.4%FY 2026: 76.8%
FY 2017 FY 2026
Free Cash Flow -17.5%
FY 2017: -7561.1%FY 2018: -44.8%FY 2019: 49.1%FY 2020: -124.4%FY 2021: -15.6%FY 2022: -147.8%FY 2023: -32.8%FY 2024: 5.7%FY 2025: 18.4%FY 2026: -17.5%
FY 2017 FY 2026

Financial Health

Current Ratio 1.3×
FY 2017: 0.1×FY 2018: 25.0×FY 2019: 1.3×FY 2020: 1.8×FY 2021: 3.2×FY 2022: 12.4×FY 2023: 2.0×FY 2024: 0.1×FY 2025: 6.6×FY 2026: 1.3×
FY 2017 5y median 2.0× FY 2026
Quick Ratio 1.3×
FY 2017: 0.1×FY 2018: 25.0×FY 2019: 1.3×FY 2020: 1.8×FY 2021: 3.2×FY 2022: 12.4×FY 2023: 2.0×FY 2024: 0.1×FY 2025: 6.6×FY 2026: 1.3×
FY 2017 5y median 2.0× FY 2026
Debt / Equity 0.0×
FY 2017: -1.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -0.1×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.1×
FY 2017: 1477×FY 2018: -73.4×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: 1.1×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.9×FY 2026: 0.1×
FY 2017 5y median 0.3× FY 2026
Interest Coverage 1324×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -31.2×FY 2022: -265×FY 2023: -1931×FY 2024: -984×FY 2025: -249×FY 2026: 1324×
FY 2017 5y median -265× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-04-30